0001179110-16-024748.txt : 20160516 0001179110-16-024748.hdr.sgml : 20160516 20160516161052 ACCESSION NUMBER: 0001179110-16-024748 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160509 FILED AS OF DATE: 20160516 DATE AS OF CHANGE: 20160516 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOANALYTICAL SYSTEMS INC CENTRAL INDEX KEY: 0000720154 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 351345024 STATE OF INCORPORATION: IN FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 2701 KENT AVE CITY: WEST LAFAYETT STATE: IN ZIP: 47906-1382 BUSINESS PHONE: 3174634527 MAIL ADDRESS: STREET 1: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blumhoff Jill CENTRAL INDEX KEY: 0001674234 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23357 FILM NUMBER: 161653844 MAIL ADDRESS: STREET 1: C/O BIOANALYTICAL SYSTEMS, INC. STREET 2: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 3 1 edgar.xml FORM 3 - X0206 3 2016-05-09 0 0000720154 BIOANALYTICAL SYSTEMS INC BASI 0001674234 Blumhoff Jill 2701 KENT AVENUE WEST LAFAYETTE IN 47906 0 1 0 0 VP, Finance & CFO Employee Stock Option (right to buy) 5.09 2018-09-04 Common Shares 2000 D Employee Stock Option (right to buy) 1.01 2020-08-15 Common Shares 2000 D Employee Stock Option (right to buy) 1.40 2023-01-16 Common Shares 500 D Employee Stock Option (right to buy) 1.70 2025-09-14 Common Shares 10000 D The option became exercisable in four equal annual installments. The first installment became exercisable on September 4, 2010, and the next three installments became exercisable on September 4, 2011, September 4, 2012 and September 4, 2013. The option became exercisable in four equal annual installments. The first installment became exercisable on August 16, 2012, and the next three installments became exercisable on August 16, 2013, August 16, 2014 and August 16, 2015. The option became exercisable in two equal annual installments. The first installment became exercisable on January 16, 2014 and the second installment became exercisable on January 16, 2015. The option will become exercisable in four equal annual installments. The first installment will become exercisable on September 15, 2016, and the next three installments will become exercisable on September 15, 2017, September 15, 2018 and September 15, 2019. Exhibit List:Exhibit 24.1--Power of Attorney /s/ Jill C. Blumhoff 2016-05-16 EX-24 2 ex24basiblum.txt Exhibit 24.1 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints Jacqueline M. Lemke as the undersigned's true and lawful attorney-in-fact to: 1. Execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Bioanalytical Systems, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder; 2. Do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto and timely file such form with the United States Securities and Exchange Commission and any national quotation system, national securities exchange, stock exchange or similar authority; and 3. Take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of or legally required by the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 16th day of May, 2016. /s/ Jill C. Blumhoff ----------------------------------- Signature Jill c. Blumhoff ------------------------------------ Print